Morphine Completed Phase 4 Trials for Solitary Mass / Chronic Lung Diseases Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01236495 | Comparison for Pethidine Requirement in Patients Received Spinal Morphine 0.2 and 0.3 mg for Post Lobectomy Analgesia |